Fagron Compounding Services recalls
Fagron Compounding Services has 13 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 15 Apr 2026. 9 are still ongoing. 7 were reported in the last 12 months. The most frequent reason is sterility.
Total recalls13since 2017
Last 12 months7reported
Class I215% of total
Ongoing9latest 15 Apr 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 15%Class II 10 77%Class III 1 8%
Why fagron compounding services is recalled
Product types
By year
Ongoing fagron compounding services recalls
9 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Vancomycin HCL added to, 9% Sodium Chloride Injection recalled | Fagron Compounding Services | Sterility | Nationwide |
| Drug | CLASS II | norepinephrine Bitartrate,16mg per 9% Sodium Chloride recalled | Fagron Compounding Services | Sterility | Nationwide |
| Drug | CLASS II | norepinephrine Bitartrate, 32mg per 9% Sodium Chloride recalled | Fagron Compounding Services | Sterility | Nationwide |
| Drug | CLASS II | Vancomycin HCI added to, 9% Sodium Chloride Injection recalled | Fagron Compounding Services | Sterility | Nationwide |
| Drug | CLASS II | Vancomycin HCI added to, 9% Sodium Chloride Injection recalled | Fagron Compounding Services | Sterility | Nationwide |
| Drug | CLASS II | Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 5%/Ketorolac recalled | Fagron Compounding Services | Sterility | Nationwide |
All fagron compounding services recalls, newest first
13 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.